Tim is a Partner, Head of Research and a co-founding member of Cowen Healthcare Investments. Tim focuses on investments in life science and digital medicine companies that have the potential to meaningfully address serious medical conditions. He is currently a member of the Board of Directors of Anaveon, Lycia Therapeutics, F2G and Autobahn Therapeutics. Tim previously served as a Board Member or Board Observer of Vectiv Bio Holdings AG, Therachon, Precision Biosciences, Livongo Health, Cadent Therapeutics, Cullinan Oncology and Compass Therapeutics. Tim holds a BA in economics from Bowdoin College.
Likes
Share It 
